Testing bisoprolol and verapamil in hypertrophic heart disease
Treatments studied
Part of Heart & circulation clinical trials.
This study tests whether two common heart medicines, bisoprolol and verapamil, improve symptoms in adults with non-obstructive hypertrophic cardiomyopathy. It may help you and your care team understand which medicine works better for symptom control and heart function.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have non-obstructive hypertrophic cardiomyopathy with thickened heart muscle (wall thickness at least 15 mm) not caused by other diseases like uncontrolled high blood pressure, valve problems, or storage diseases
- You have symptoms or heart strain, such as at least NYHA class II, a past history of NYHA class II, high BNP/Pro-BNP blood test levels, or non-sustained fast rhythm on a recent heart recording
- Your heart pumping strength (ejection fraction) is 50% or higher
- Your heart’s outflow blockage is not too high (LVOT gradient 30 mmHg or less at rest or during certain maneuvers)
- You can understand study information and do required tests (including an exercise test) and can communicate in Danish
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new medicine, BHB-1893, against a common heart medicine called metoprolol for people with a heart condition that makes it harder for the heart to pump blood. The goal is to see if BHB-1893 improves symptoms like chest pain and shortness of breath better than the standard medicine.
This trial tests whether a genetic test can help doctors choose the best beta blocker for people with heart failure who have mildly reduced pumping function. It aims to improve treatment by matching the drug to your genetic profile.
This study looks at how mineralocorticoid-related hormone signaling affects small heart blood vessels and how efficiently the heart works in people with high blood pressure. It may help doctors understand which treatments could improve heart function in hypertension.
This trial tests if baxdrostat can improve heart muscle structure in people with high blood pressure and a thickened heart wall. You may qualify if you have hypertension and evidence of left ventricular hypertrophy.
This trial tests a new medicine, HJB647, in people with heart failure who have a weak heart pump. It aims to see if the drug is safe and well-tolerated. You may qualify if your heart's pumping ability is reduced and you are on a specific standard therapy.
This study tests whether a 24-week exercise program can improve exercise tolerance in people with hypertrophic cardiomyopathy (a thickened heart muscle). You may be asked to use phone-based tools and complete surveys during training.
Hear when a new Non-obstructive Hypertrophic Cardiomyopathy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.